CD44 and Miyoshi myopathy: CD44 is a surface marker of breast, gastric, and colon cancer stem cells [76], and CD44 is closely related to the cell adhesion-mediated drug resistance of MM cells [77,78], which suggests that CD44 may also serve as a marker of MM stemness.